Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents for neurodegenerative disorders to the CNS: implications for treating neuroAIDS
Overview
authors
Frey II, William H., PhD
publication date
2006
Research
keywords
Blood
Brain
Drugs
HIV-AIDS
Intranasal Administration
Therapy